Genitourinary Radiology: Page 89

Analysis of 3-D Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer
By Ultrasound Review
(Ultrasound Review) According to radiologists at the University of Michigan, color Doppler ultrasound provides information that enables discrimination between normal prostatic tissue and cancer.
August 8, 2001
Burdette names new sales and marketing VP
Burdette Medical Systems, a developer of ultrasound-guided prostate cancer treatment planning devices, has appointed John Patterson as vice president of sales and marketing.
August 5, 2001
RF ablation for genitourinary carcinoma aces strict cost-effectiveness criteria
By Shalmali Pal
With as few as 10% of liver or colorectal cancer patients meeting eligibility for surgical resection, percutaneous radiofrequency ablation is an appealing alternative -- but at what cost? Investigators from several Massachusetts institutes set out to determine the cost-effectiveness of RF ablation.
July 30, 2001
Optimizing CT protocols for liver lesions
By Shalmali Pal
The ability of CT to detect liver masses is dependent on the scanning technique used. Dr. Rendon Nelson from Duke University in Durham, NC, outlined the protocols his group uses for hepatic CT at the 2001 International Symposium on Multidetector-Row CT.
July 22, 2001
Brachytherapy seeds for prostate cancer can migrate to lungs
By Edward Susman
The dozens of radioactive seeds implanted in and around cancerous prostate glands during brachytherapy can slip into the nearby vascular system and migrate to other organs, according to a presentation at the 2001 American Urological Society meeting in Anaheim, CA.
June 17, 2001
2001 06 15 15 23 06 706
Cancer Profiler helps prostate cancer patients
By AuntMinnie.com staff writers
The Cancer Profiler, featured on the American Cancer Society Web site, aids prostate cancer patients and physicians in their research for treatment options using published medical studies.
June 10, 2001
ACS offers free prostate cancer newsletter
By AuntMinnie.com staff writers
The American Cancer Society is providing its newsletter, "Man to Man News," free of charge to prostate cancer patients, survivors, and medical professionals.
June 10, 2001
Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease
By Ultrasound Review
(Ultrasound Review) The aim of a study conducted by the University of Helsinki in Finland was to evaluate the usefulness of power Doppler transvaginal ultrasound to determine the diagnostic reliability of sonographic findings.
June 3, 2001
FDA approves Nycomed Amersham's EchoSeed
By AuntMinnie.com staff writers
Nycomed Amersham Imaging has received FDA clearance to market EchoSeed, a new brachytherapy product the company says will maximize patient care.
June 3, 2001
CT illuminates mysteries of LAM
By Eric Barnes
SAN FRANCISCO - Lymphangioleiomyomatosis (LAM) is a giant word for a medical enigma. A rare multisystem disorder that strikes only premenopausal women, LAM isn't cancer but can be just as deadly. There's no cure yet, but CT is helping doctors answer some critical questions.
May 22, 2001
Sonazoid boosts ultrasound prowess in liver and prostate
By Dan Krotz
Sonazoid, an ultrasound contrast agent that differentiates normal from abnormal organ tissue, passed preliminary muster both for detecting liver lesions and enhancing the prostate, say two studies presented at the 2001 American Institute of Ultrasound in Medicine meeting in Orlando.
May 20, 2001
2001 05 18 16 08 59 706
Nycomed gets sole-source TheraSeed deal from Premier
By AuntMinnie.com staff writers
Nycomed Amersham Imaging has signed a two-year, sole-source agreement to provide group purchasing organization Premier with its TheraSeed palladium-103 prostate brachytherapy seed.
May 8, 2001
Previous Page
Page 89 of 93
Next Page